These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 19687782
21. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, Kalsy SA, Zinsmeister AR. Gastroenterology; 2008 Oct; 135(4):1142-54. PubMed ID: 18725220 [Abstract] [Full Text] [Related]
25. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Elfhag K, Finer N, Rössner S. Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239 [Abstract] [Full Text] [Related]
26. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome. Georgopoulos NA, Katsikis I, Florakis D, Panidis D, Kandarakis ED. Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719 [No Abstract] [Full Text] [Related]
27. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. Bauer C, Fischer A, Keller U. Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988 [Abstract] [Full Text] [Related]
28. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients. Finer N, Ryan DH, Renz CL, Hewkin AC. Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525 [Abstract] [Full Text] [Related]
30. Influence of sibutramine, orlistat and Ispaghula in reducing body weight and total body fat content in obese individuals. Kazmi SA, Khan M, Mashori GR, Saleem A, Akhtar N, Jahangeer A. J Ayub Med Coll Abbottabad; 2009 Mar; 21(2):45-8. PubMed ID: 20524467 [Abstract] [Full Text] [Related]
31. The guanine nucleotide binding protein beta polypeptide 3 gene C825T polymorphism is associated with elite endurance athletes. Eynon N, Oliveira J, Meckel Y, Sagiv M, Yamin C, Sagiv M, Amir R, Duarte JA. Exp Physiol; 2009 Mar; 94(3):344-9. PubMed ID: 19139061 [Abstract] [Full Text] [Related]
34. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox. Barratt R, Frost G, O'Boyle A, Millward J, Truby H. J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180 [Abstract] [Full Text] [Related]
35. Clinical evaluation of sibutramine in obese type 2 diabetic patients refractory to dietary management. Sircar AR, Kumar A, Lal M. J Assoc Physicians India; 2001 Sep; 49():885-8. PubMed ID: 11837755 [Abstract] [Full Text] [Related]
38. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study. Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS. Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651 [Abstract] [Full Text] [Related]
39. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Kim SH, Lee YM, Jee SH, Nam CM. Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682 [Abstract] [Full Text] [Related]